Tag: TherapeuticsMD

  • Top Stories: Aetna Inc. (NYSE:AET), Salix Pharmaceuticals (NASDAQ:SLXP), USANA Health Sciences (NYSE:USNA), TherapeuticsMD Inc. (NYSEMKT:TXMD), Daimler AG (USA)(OTCMKTS:DDAIF)

    Health insurer Aetna Inc. (NYSE:AET) has a goal of transitioning providers to accepting 100 percent of payments electronically through an electronic funds transfer, as well all providers receiving electronic remittance advice. Aetna Inc. (NYSE:AET) net profit margin is 4.00% and weekly performance is 1.40%. On last trading day company shares ended up $74.73. Analysts mean target price for the company is $82.94. Aetna Inc. (NYSE:AET) distance from 50-day simple moving average (SMA50) is 2.70%.

    Salix Pharmaceuticals, Ltd. logo Leerink Swann reiterated their outperform rating on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research report sent to investors on Wednesday morning, Stock Ratings Network reports. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) shares advanced 1.25% in last trading session and ended the day on $106.90. SLXP gross Margin is 76.50% and its return on assets is 6.40%.Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) quarterly performance is 4.62%.

    USANA Health Sciences (NASDAQ:USNA) Insider Deborah Woo unloaded 11,336 shares of the stock on the open market in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $70.03, for a total value of $793,860.08. USANA Health Sciences, Inc. (NYSE:USNA) shares moved down -1.00% in last trading session and was closed at $68.06, while trading in range of $67.23 – $68.42. USANA Health Sciences, Inc. (NYSE:USNA) year to date (YTD) performance is -9.95%.

    TherapeuticsMD Inc. (NYSEMKT:TXMD) Revenues for the three months ended March 31, 2014 increased approximately $1,294,000 or approximately 84%, from the three months ended March 31, 2013. TherapeuticsMD Inc. (NYSEMKT:TXMD) ended the last trading day at $3.73. Company weekly volatility is calculated as 8.36% and price to cash ratio as 10.01.TherapeuticsMD Inc. (NYSEMKT:TXMD) showed a positive weekly performance of 8.75%.

    Daimler AG (USA)(OTCMKTS:DDAIF) the Stuttgart, Germany-based owner of Mercedes, and Volkswagen AG’s Audi have both vowed to take the global premium-car sales crown from Munich-based BMW by the end of the decade. The three manufacturers are forecasting at least a fourth year of record vehicle sales for 2014 as demand revives in their home market of Europe. BMW, which took first place from Mercedes in 2005, plans annual group sales exceeding 2 million vehicles for the first time this year. On last trading day company shares ended up $90.63.